Boston ratchets up Watchman efforts as clinical data builds
This article was originally published in Clinica
Executive Summary
Medtech companies chomping at the bit to see their new product take off in the market might do well to heed the advice of Kenneth Stein, senior vice-president and chief medical officer of Boston Scientific’s cardiac rhythm management division: “There is a natural process in the adoption of technology; you wouldn’t want to see your technology going ahead of clinical evidence.”